| Literature DB >> 26004086 |
Céline Baldeyron1, Amélie Brisson1, Bruno Tesson2, Fariba Némati3, Stéphane Koundrioukoff4, Elie Saliba1, Leanne De Koning5, Elise Martel6, Mengliang Ye1, Guillem Rigaill7, Didier Meseure6, André Nicolas6, David Gentien8, Didier Decaudin3, Michelle Debatisse4, Stéphane Depil9, Francisco Cruzalegui9, Alain Pierré9, Sergio Roman-Roman1, Gordon C Tucker9, Thierry Dubois10.
Abstract
Triple-negative breast cancer (TNBC) is the breast cancer subgroup with the most aggressive clinical behavior. Alternatives to conventional chemotherapy are required to improve the survival of TNBC patients. Gene-expression analyses for different breast cancer subtypes revealed significant overexpression of the Timeless-interacting protein (TIPIN), which is involved in the stability of DNA replication forks, in the highly proliferative associated TNBC samples. Immunohistochemistry analysis showed higher expression of TIPIN in the most proliferative and aggressive breast cancer subtypes including TNBC, and no TIPIN expression in healthy breast tissues. The depletion of TIPIN by RNA interference impairs the proliferation of both human breast cancer and non-tumorigenic cell lines. However, this effect may be specifically associated with apoptosis in breast cancer cells. TIPIN silencing results in higher levels of single-stranded DNA (ssDNA), indicative of replicative stress (RS), in TNBC compared to non-tumorigenic cells. Upon TIPIN depletion, the speed of DNA replication fork was significantly decreased in all BC cells. However, TIPIN-depleted TNBC cells are unable to fire additional replication origins in response to RS and therefore undergo apoptosis. TIPIN knockdown in TNBC cells decreases tumorigenicity in vitro and delays tumor growth in vivo. Our findings suggest that TIPIN is important for the maintenance of DNA replication and represents a potential treatment target for the worst prognosis associated breast cancers, such as TNBC.Entities:
Keywords: Apoptosis; Basal-like; Replicative stress; TIPIN; Therapeutic target; Triple-negative breast cancer
Mesh:
Substances:
Year: 2015 PMID: 26004086 PMCID: PMC5528799 DOI: 10.1016/j.molonc.2015.04.010
Source DB: PubMed Journal: Mol Oncol ISSN: 1574-7891 Impact factor: 6.603